Related Experiment Video
Updated: Aug 23, 2025
17:16
Registered Bioimaging of Nanomaterials for Diagnostic and Therapeutic Monitoring
Published on: December 9, 2010
10.4K
Nanoparticle Diagnostics and Theranostics in the Clinic.
Roger M Pallares1, Felix M Mottaghy2,3, Volkmar Schulz4,5
1Institute for Experimental Molecular Imaging, RWTH Aachen University Hospital, Aachen, Germany; rmoltopallar@ukaachen.de tlammers@ukaachen.de.
Summary
Nanoparticles offer unique diagnostic and therapeutic potential. This review covers nanoparticle imaging agents in clinical use and explores future diagnostic and theranostic applications.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Medical Imaging
Background:
- Nanoparticles exhibit unique properties beneficial for medical applications.
- Numerous nanoparticle diagnostic tools have been developed preclinically.
- Clinical translation of nanodiagnostics remains limited.
Purpose of the Study:
- To review current nanoparticle-based imaging agents in clinical use.
- To discuss preclinical advancements in nanoparticle diagnostics and therapeutics.
- To explore translational strategies for nanoparticle theranostics.
Main Methods:
- Literature review of clinical and preclinical studies.
- Analysis of nanoparticle imaging agents.
- Discussion of translational challenges and opportunities.
Main Results:
- Several nanoparticle imaging agents are approved or under clinical evaluation.
- Significant preclinical progress exists for various diagnostic and therapeutic nanoparticle applications.
- Translational hurdles impact the clinical adoption of nanomedicine.
Conclusions:
- Nanoparticles show promise for advanced disease diagnosis and therapy.
- Bridging the gap between preclinical research and clinical application is crucial.
- Further development is needed to realize the full theranostic potential of nanoparticles.
